1. Structural and morphological changes of breast cancer cells induced by iron(ii) complexes
   Janske Nel et al, 2022, Nanoscale CrossRef
2. Overview of Basic Mechanisms of Notch Signaling in Development and Disease
   Brendan McIntyre et al, 2020, Notch Signaling in Embryology and Cancer CrossRef
3. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel
   Mina Rasoolnezhad et al, 2023, Molecular Biology Reports CrossRef
4. Moving Breast Cancer Therapy up a Notch
   Erik W. J. Mollen et al, 2018, Frontiers in Oncology CrossRef
5. Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
   Bruno de Paula et al, 2023, Molecular Cancer Therapeutics CrossRef
6. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation
   Narges Dastmalchi et al, 2021, Molecular Biology Reports CrossRef
7. Opportunities, obstacles and current challenges of flavonoids for luminal and triple-negative breast cancer therapy
   Vanina S. Vachetta et al, 2022, European Journal of Medicinal Chemistry Reports CrossRef
8. Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
   Sangita Sridharan et al, 2019, Frontiers in Oncology CrossRef
9. “Double-punch” strategy against triple-negative breast cancer via a synergistic therapy of magneto-mechanical force enhancing NIR-II hypothermal ablation
   Hui Du et al, 2022, Biomaterials CrossRef
10. Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
    Patrick G. Morris et al, 2018, Clinical Breast Cancer CrossRef
11. Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
    Venus Sosa Iglesias et al, 2018, Frontiers in Oncology CrossRef
12. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro
    Liu Yang et al, 2018, Breast Cancer Research CrossRef
13. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells
    Yamila Sanchez et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
14. Molecularly Engineered Surfactin Analogues Induce Nonapoptotic-Like Cell Death and Increased Selectivity in Multiple Breast Cancer Cell Types
    Rebecca T. Miceli et al, 2023, ACS Omega CrossRef